(Rac) -ACT-451840
(Rac) -ACT-451840 is an isomer of ACT-451840 that exhibits significant antimalarial effects. (Rac) -ACT-451840 exhibits significant antimalarial activity against P. berghei-infected mice at a dose of 20 mg/kg (ED90=13 mg/kg), and has an inhibitory effect at a dose of 300 mg/kg. The ED90 of (Rac) -ACT-451840 in the P. falciparum humanized immunodeficient mouse model is 3.7 mg/kg. (Rac) -ACT-451840 is similar to artemisinin, with a rapid onset of action but requires repeated high doses.
Product Specifications
CAS Number
1839508-99-4
UNSPSC
12352005
Target
Parasite
Type
Reference compound
Related Pathways
Anti-infection
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/rac-act-451840.html
Smiles
CC(N(CC1)CCN1C(C=C2)=CC=C2CN(C(/C=C/C3=CC=C(C=C3)C(C)(C)C)=O)C(CC4=CC=CC=C4)C(N5CCN(CC5)CC6=CC=C(C=C6)C#N)=O)=O
Molecular Formula
C47H54N6O3
Molecular Weight
750.97
References & Citations
[1]Discovery and characterization of ACT‐451840: an antimalarial drug with a novel mechanism of action
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Laminin 2 alpha (LAMA2) Human Gene Knockout Kit (CRISPR)
Microphthalmia Transcription Factor (MITF) (MITF/2987R), Biotin conjugate, 0.1mg/mL
Caspase 1 (CASP1) (NM_001223) Human Over-expression Lysate
